Pacific Biosciences of California, Inc. (PACB)
1.285
-0.06
(-4.81%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.04
(+3.50%)
After-Hours: 20:00
Pacific Biosciences of California Net Income (Quarterly) : -44.74M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.74M |
| March 31, 2026 | -8.275M |
| December 31, 2025 | -40.37M |
| September 30, 2025 | -38.00M |
| June 30, 2025 | -41.93M |
| March 31, 2025 | -426.08M |
| December 31, 2024 | 3.571M |
| September 30, 2024 | -60.72M |
| June 30, 2024 | -173.32M |
| March 31, 2024 | -78.18M |
| December 31, 2023 | -82.02M |
| September 30, 2023 | -66.87M |
| June 30, 2023 | -69.83M |
| March 31, 2023 | -88.02M |
| December 31, 2022 | -84.38M |
| September 30, 2022 | -76.97M |
| June 30, 2022 | -71.39M |
| March 31, 2022 | -81.50M |
| December 31, 2021 | -69.33M |
| September 30, 2021 | 16.54M |
| June 30, 2021 | -41.00M |
| March 31, 2021 | -87.44M |
| December 31, 2020 | 74.94M |
| September 30, 2020 | -23.71M |
| June 30, 2020 | -23.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.262M |
| December 31, 2019 | -0.091M |
| September 30, 2019 | -29.12M |
| June 30, 2019 | -24.60M |
| March 31, 2019 | -30.32M |
| December 31, 2018 | -30.80M |
| September 30, 2018 | -25.04M |
| June 30, 2018 | -22.54M |
| March 31, 2018 | -24.18M |
| December 31, 2017 | -20.76M |
| September 30, 2017 | -22.02M |
| June 30, 2017 | -25.54M |
| March 31, 2017 | -23.87M |
| December 31, 2016 | -19.03M |
| September 30, 2016 | -17.49M |
| June 30, 2016 | -18.50M |
| March 31, 2016 | -19.35M |
| December 31, 2015 | -1.409M |
| September 30, 2015 | 1.821M |
| June 30, 2015 | -11.94M |
| March 31, 2015 | -20.17M |
| December 31, 2014 | -18.98M |
| September 30, 2014 | -9.163M |
| June 30, 2014 | -19.14M |
| March 31, 2014 | -18.89M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Illumina, Inc. | 207.00M |
| Agilent Technologies, Inc. | 339.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Danaher Corp. | 870.00M |
| Thermo Fisher Scientific, Inc. | 1.742B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 39.01M |
| Total Expenses (Quarterly) | 83.75M |
| EPS Diluted (Quarterly) | -0.144 |
| Enterprise Value | 888.81M |
| Gross Profit Margin (Quarterly) | 30.26% |
| Profit Margin (Quarterly) | -114.7% |
| Earnings Yield | -33.55% |
| Normalized Earnings Yield | -30.54 |